Abstract
Background: Distant metastases from carcinomas that arise from the head and neck region are infrequent. The most common site is the lung. To evaluate the results of resection of pulmonary metastases for head and neck cancers, we reviewed our own cases of these metastases.
Methods: Between November 1966 and March 1995, 83 patients with pulmonary metastases from head and neck cancers underwent 94 thoracic operations. All patients had obtained or had obtainable locoregional control of their primary head and neck cancers. Kaplan-Meier and Cox regression models were used to analyze the prognostic factors for survival after metastasectomy.
Results: Median age was 53 years (range, 17–77). Fifty-nine were male and 24 were female. Forty-one patients had squamous cell cancers, and 36 had glandular tumors that consisted mostly of thyroid and adenoid cystic carcinomas. The median disease-free interval from the time of treatment of the head and neck primary cancers to the development of pulmonary metastases was 27 months. Sixty-eight (82%) patients had complete resection. Overall operative mortality rate was 2%. Overall actuarial survival rate after metastasectomy was 50% at 5 years. Patients with glandular tumors had a 5-year survival rate of 64% compared with 34% for patients with squamous cell cancers. When the patients with glandular tumors were analyzed according to their histology, patients with adenoid cystic carcinomas had an 84% 5-year survival, but none remained disease-free. Patients with thyroid cancers fared similarly whether they were treated medically or surgically. On multivariate analysis, the adverse prognostic factors for patients with squamous cell cancers were incomplete resection, age greater than 50 years, and disease-free interval less than or equal to 2 years.
Conclusions: Approximately 30% of patients with pulmonary metastases from squamous cell cancers of the head and neck who underwent complete resection of all their metastases can expect to achieve long-term survival. The role of pulmonary resection for patients with glandular tumors is unclear.
Similar content being viewed by others
REFERENCES
Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin 1998;48:6–29.
Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg 1975;70:606–612.
Vikram BV, Strong EW, Shah JP, Spiro R. Failure at distant sites following multimodality treatment for advanced head and neck cancer. Head Neck Surg 1984;6:730–733.
Dennington ML, Carter DR, Meyers AD. Distant metastases in head and neck epidermoid carcinoma. Laryngoscope 1980;90:196–201.
Merino OR, Lindberg RD, Fletcher GH. An analysis of distant metastases from squamous cell cancers of the upper respiratory and digestive tracts. Cancer 1977;40:145–151.
Calhoun KH, Fulmer P, Weiss R, Hokanson JA. Distant metastases from head and neck squamous cell carcinomas. Laryngoscope 1994;104:1199–1205.
Papac RJ. Distant metastases from head and neck cancer. Cancer 1984;53:342–345
Lefor AT, Bredenberg CE, Kellman RM, Aust JC. Multiple malignancies of the lung and head and neck. Arch Surg 1986;121:265–270.
McCormack P. Surgical resection of pulmonary metastases. Semin Surg Oncol 1990;6:297–302.
Mazer TM, Robbins KT, McMurtrey MJ, Byers RM. Resection of pulmonary metastases from squamous carcinoma of the head and neck. Am J Surg 1988;156:238–242.
Finley RK, Verazin GT, Driscoll DL, et al. Results of surgical resection of pulmonary metastases of squamous cell carcinoma of the head and neck. Am J Surg 1992;164:594–598.
Wedman J, Balm AJM, Hart AAM, et al. Value of resection of pulmonary metastases in head and neck cancer patients. Head Neck 1996;18:311–316.
Schlumberger M, Challeton C, De Vathaire F, et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 1996;37:598–605.
Kim KH, Sung MW, Chung PS, et al. Adenoid cystic carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1994;120:721–726.
The International Registry of Lung Metastases. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg 1997;113:37–49.
Shaha AR, Hoover EL, Mitrani M, et al. Synchronicity, multicentricity, and metachronicity of head and neck cancer. Head Neck Surg 1988;10:225–228.
Deleyiannis FW, Thomas DB. Risk of lung cancer among patients with head and neck cancer. Otolaryngol Head Neck Surg 1997;116:630–636.
Vikram B, Strong EW, Shah JP, Spiro R. Second malignant neoplasms in patients successfully treated with multimodality treatment for advanced head and neck cancer. Head Neck Surg 1984;6:734–737.
Sercarz J, Ellison D, Holmes EC, Calcaterra TC. Isolated pulmonary nodules in head and neck cancer patients. Ann Otol Rhinol Laryngol 1989;98:113–118.
Chung KY, Mukhopadhyay T, Kim J, et al. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res 1993;53:1676–1683.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, D., Labow, D.M., Dang, N. et al. Pulmonary Metastasectomy for Head and Neck Cancers. Ann Surg Oncol 6, 572–578 (1999). https://doi.org/10.1007/s10434-999-0572-8
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10434-999-0572-8